Skip to main content
. Author manuscript; available in PMC: 2021 Jul 27.
Published in final edited form as: J Pediatr Gastroenterol Nutr. 2021 Apr 1;72(4):520–527. doi: 10.1097/MPG.0000000000003010

TABLE 1.

Individual demographics

N = 25 Off acid blockade (N = 14) On acid blockade (N = 11)*
Female sex 11 (44%) 7 (50%) 4 (36%)
Age, years; median [IQR] 13.8 [11.2–14.8] 13.5 [11.2–14.7] 13.8 [11.2–15.5]
Genotype
 F508/F508 11 (44%) 6 (43%) 5 (45%)
 F508/other 12 (48%) 7 (50%) 5 (45%)
 Other/other 2 (8%) 1 (7%) 1 (9%)
Race
 Caucasian 24 (96) 13 (93%) 11 (100%)
 African American 1 (4%) 1 (7%) 0
Hispanic or Latino Ethnicity 3 (12%) 2 (14%) 1 (9%)
BMI percentile, median [IQR] 58 [37–78] 63 [38–78] 54 [33–76]
FEV1% predicted, median [IQR] 92 [85–100] 96 [88–102] 88 [85–94]
On CFTR modulators 15 (60%) 9 (64%) 6 (55%)
On PPI medications 11 (44%) 6 (55%)
*

Two individuals from the cross over study design are included.